ATE356205T1 - Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen - Google Patents

Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen

Info

Publication number
ATE356205T1
ATE356205T1 AT97913053T AT97913053T ATE356205T1 AT E356205 T1 ATE356205 T1 AT E356205T1 AT 97913053 T AT97913053 T AT 97913053T AT 97913053 T AT97913053 T AT 97913053T AT E356205 T1 ATE356205 T1 AT E356205T1
Authority
AT
Austria
Prior art keywords
protein
lait
cells
activation
bovine
Prior art date
Application number
AT97913053T
Other languages
English (en)
Inventor
Michael H Julius
Dominik Filipp
Kamel Alizadeh-Khiavi
Original Assignee
Arthritis & Autoimmunity Res C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthritis & Autoimmunity Res C filed Critical Arthritis & Autoimmunity Res C
Application granted granted Critical
Publication of ATE356205T1 publication Critical patent/ATE356205T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97913053T 1996-11-18 1997-11-18 Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen ATE356205T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/746,883 US6093693A (en) 1996-11-18 1996-11-18 B cell activation

Publications (1)

Publication Number Publication Date
ATE356205T1 true ATE356205T1 (de) 2007-03-15

Family

ID=25002765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97913053T ATE356205T1 (de) 1996-11-18 1997-11-18 Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen

Country Status (16)

Country Link
US (4) US6093693A (de)
EP (2) EP1801216A3 (de)
JP (1) JP4447058B2 (de)
CN (1) CN100516215C (de)
AT (1) ATE356205T1 (de)
AU (1) AU732476B2 (de)
BR (1) BR9713096A (de)
CA (1) CA2272051C (de)
CZ (1) CZ300752B6 (de)
DE (1) DE69737456T2 (de)
DK (1) DK0941322T3 (de)
ES (1) ES2284183T3 (de)
HU (1) HU226217B1 (de)
IL (1) IL129855A (de)
PL (1) PL193670B1 (de)
WO (1) WO1998022580A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU771448B2 (en) * 1998-05-27 2004-03-25 Gemma Biotechnology Ltd. The induction of antibiotic proteins and peptides by LAIT/sCD14-protein
CA2347069A1 (en) * 1998-10-20 2000-04-27 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gastrointestinal tract disorder
EP1111388A1 (de) * 1999-12-23 2001-06-27 Universiteit Gent Interaktion zwischen CD14 und HBV-Komponenten
US6984503B1 (en) * 2002-06-27 2006-01-10 The United States Of America As Represented By The Secretary Of The Agriculture Use of recombinant bovine CD14 in the treatment and prevention of coliform mastitis in dairy cows
ATE380825T1 (de) * 2003-03-11 2007-12-15 Regen Therapeutics Plc Aufreinigung von peptiden aus kolostrum
ES2232273B1 (es) * 2003-03-21 2006-07-16 Jose Manuel Fernandez-Real Lemos Nuevas aplicaciones terapeuticas de la glucoproteina cd14s.
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
US11206843B1 (en) * 2020-05-26 2021-12-28 BIOMILQ, Inc. Milk product compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) * 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
EP0485430B1 (de) * 1989-08-01 1998-09-16 The Scripps Research Institute Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis
WO1993019772A1 (en) * 1992-04-06 1993-10-14 North Shore University Hospital Research Corporation A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen
CA2163976C (en) * 1993-05-28 2010-06-29 Didier J. Leturcq Methods and compositions for inhibiting cd14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
US5766593A (en) * 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
JPH10512142A (ja) * 1994-12-30 1998-11-24 アムジエン・インコーポレーテツド 抗炎症性ｃｄ１４ポリペプチド
WO1996032418A1 (en) * 1995-04-13 1996-10-17 Laboratoires Om S.A. Anti-cd14 antibodies for use in the induction of il-10 secretion
US6168787B1 (en) * 1995-04-24 2001-01-02 John Wayne Cancer Institute Pluripotent vaccine against enveloped viruses
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
IL129855A0 (en) 2000-02-29
CN1238010A (zh) 1999-12-08
CA2272051C (en) 2012-09-18
PL333413A1 (en) 1999-12-06
EP1801216A3 (de) 2007-11-07
ES2284183T3 (es) 2007-11-01
US6676985B1 (en) 2004-01-13
BR9713096A (pt) 2000-10-24
HU226217B1 (en) 2008-06-30
CN100516215C (zh) 2009-07-22
WO1998022580A2 (en) 1998-05-28
JP4447058B2 (ja) 2010-04-07
IL129855A (en) 2013-06-27
WO1998022580A3 (en) 1998-10-01
AU5045198A (en) 1998-06-10
HUP0001057A3 (en) 2002-09-30
CZ300752B6 (cs) 2009-08-05
US6093693A (en) 2000-07-25
DE69737456T2 (de) 2007-11-29
EP1801216A2 (de) 2007-06-27
US20070014809A1 (en) 2007-01-18
PL193670B1 (pl) 2007-03-30
JP2001504695A (ja) 2001-04-10
US20040258704A1 (en) 2004-12-23
EP0941322A2 (de) 1999-09-15
DK0941322T3 (da) 2007-06-25
EP0941322B1 (de) 2007-03-07
DE69737456D1 (de) 2007-04-19
AU732476B2 (en) 2001-04-26
CA2272051A1 (en) 1998-05-28
HUP0001057A2 (hu) 2000-08-28
CZ175199A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
EP0210189A4 (de) Rekombinantes alveolares oberflächenaktives protein.
IL85411A0 (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
ZA943465B (en) Transforming growth factor alpha H1
ATE105869T1 (de) Formen des koloniestimulierungsfaktors 1.
IL82364A (en) Recombinant expression system for producing alveolar surfactant protein (asp) encoded by human sp-18, human sp-5 or canine sp-5 dna; recombinant asp produced thereby and pharmaceutical compositions containing the recombinant asp
DE69533102D1 (de) Analog von haemophilus hin47 mit verminderter protease aktivität
ATE356205T1 (de) Milcherzeugungsassoziiertes immunotropisches rinderprotein (cd14), kodierendes gen und verwendung zur aktivierung von b-zellen
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
EP0770137A4 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
EP0426314A3 (en) Hiv related peptides
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
ZA200102131B (en) Method for down-regulating osteoprotegerin ligand activity.
Dukovich The Purification and Biochemical Characterization of Natural and Recombinant Interleukin 1
RU99113035A (ru) Иммунотропный белок (cd14), связанный с лактацией коров, кодирующий его ген и применение в активации b-клеток

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0941322

Country of ref document: EP